Drug Profile
FR 208419
Alternative Names: FR 202893 (as racemic); FR 208418 (as S-enantiomer)Latest Information Update: 18 Jul 2002
Price :
$50
*
At a glance
- Originator Fujisawa
- Developer Fujisawa; Nippon Shokubai
- Class Gastrokinetics
- Mechanism of Action Cholecystokinin A receptor antagonists; Cholecystokinin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 16 Jul 1998 Preclinical development for Gastrointestinal disorders in Japan (PO)